DNA therapeutics
Search documents
Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 (NASDAQ:INO)
Seeking Alpha· 2026-01-10 14:30
Company Overview - Inovio Pharmaceuticals, Inc. (INO) is a biotechnology company focused on developing DNA therapeutics targeting HPV, oncology, and infectious diseases [1]. Technology and Innovation - The company utilizes CELLECTRA electroporation devices to facilitate the introduction of DNA into cells, enabling the body to produce specific proteins [1].